<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>6984973</identifier>
<setSpec>0482-640X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Zornoza, G</dc:author>
<dc:author>Sanz, M L</dc:author>
<dc:author>Hernández, J L</dc:author>
<dc:author>Lera, J M</dc:author>
<dc:author>Fernández, J</dc:author>
<dc:author>Goena, I</dc:author>
<dc:description xml:lang="en">The authors study the amount of B cells and serum immunoglobulins in patients with mammary cancer or fibrocystic disease. They indicate that a decreasing in B cells and IgG, and an increasing in IgA are associated with a better prognosis. There is an inverse relation between the level of serum IgG and the blastic transformation of T cells by PHA, what is an indirect measure of the circulating IgG immune complexes. The presence of B cells with IgG in their surfaces makes worse the prognosis.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>1981 </dc:date>
<dc:title xml:lang="es">Estudio de células B e inmunoglobulinas séricas en enfermas con patología mamaria.</dc:title>
<dc:title xml:lang="en">[B cells and serum immunoglobulins in patients with breast pathology].</dc:title>
<dc:publisher>Revista espanola de oncologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
